|
1
|
Harbeck N and Gnant M: Breast cancer.
Lancet. 389:1134–1150. 2017. View Article : Google Scholar
|
|
2
|
Fan L, Strasser-Weippl K, Li JJ, St Louis
J, Finkelstein DM, Yu KD, Chen WQ, Shao ZM and Goss PE: Breast
cancer in China. Lancet Oncol. 15:e279–e289. 2014. View Article : Google Scholar
|
|
3
|
Sariego J: Breast cancer in the young
patient. Am Surg. 76:1397–1400. 2010.
|
|
4
|
Fillmore CM and Kuperwasser C: Human
breast cancer cell lines contain stem-like cells that self-renew,
give rise to phenotypically diverse progeny and survive
chemotherapy. Breast Cancer Res. 10:R252008. View Article : Google Scholar
|
|
5
|
Mayer IA, Abramson VG, Lehmann BD and
Pietenpol JA: New strategies for triple-negative breast cancer -
deciphering the heterogeneity. Clin Cancer Res. 20:782–790. 2014.
View Article : Google Scholar
|
|
6
|
Ward C, Langdon SP, Mullen P, Harris AL,
Harrison DJ, Supuran CT and Kunkler IH: New strategies for
targeting the hypoxic tumour microenvironment in breast cancer.
Cancer Treat Rev. 39:171–179. 2013. View Article : Google Scholar
|
|
7
|
Tang Y, Wang Y, Kiani MF and Wang B:
Classification, treatment strategy, and associated drug resistance
in breast cancer. Clin Breast Cancer. 16:335–343. 2016. View Article : Google Scholar
|
|
8
|
Semenza GL: Targeting HIF-1 for cancer
therapy. Nat Rev Cancer. 3:721–732. 2003. View Article : Google Scholar
|
|
9
|
Zepeda AB, Pessoa A Jr, Castillo RL,
Figueroa CA, Pulgar VM and Farías JG: Cellular and molecular
mechanisms in the hypoxic tissue: Role of HIF-1 and ROS. Cell
Biochem Funct. 31:451–459. 2013. View
Article : Google Scholar
|
|
10
|
Balamurugan K: HIF-1 at the crossroads of
hypoxia, inflammation, and cancer. Int J Cancer. 138:1058–1066.
2016. View Article : Google Scholar
|
|
11
|
Galanis A, Pappa A, Giannakakis A, Lanitis
E, Dangaj D and Sandaltzopoulos R: Reactive oxygen species and
HIF-1 signalling in cancer. Cancer Lett. 266:12–20. 2008.
View Article : Google Scholar
|
|
12
|
Liu ZH, Dai XM and Du B: Hes1: A key role
in stemness, metastasis and multidrug resistance. Cancer Biol Ther.
16:353–359. 2015. View Article : Google Scholar
|
|
13
|
Rani A, Greenlaw R, Smith RA and Galustian
C: HES1 in immunity and cancer. Cytokine Growth Factor Rev.
30:113–117. 2016. View Article : Google Scholar
|
|
14
|
Danza G, Di Serio C, Rosati F, Lonetto G,
Sturli N, Kacer D, Pennella A, Ventimiglia G, Barucci R, Piscazzi
A, et al: Notch signaling modulates hypoxia-induced neuroendocrine
differentiation of human prostate cancer cells. Mol Cancer Res.
10:230–238. 2012. View Article : Google Scholar
|
|
15
|
Liu J, Lu WG, Ye F, Cheng XD, Hong D, Hu
Y, Chen HZ and Xie X: Hes1/Hes5 gene inhibits differentiation via
down-regulating Hash1 and promotes proliferation in cervical
carcinoma cells. Int J Gynecol Cancer. 20:1109–1116. 2010.
View Article : Google Scholar
|
|
16
|
Yuan R, Ke J, Sun L, He Z, Zou Y, He X,
Chen Y, Wu X, Cai Z, Wang L, et al: HES1 promotes metastasis and
predicts poor survival in patients with colorectal cancer. Clin Exp
Metastasis. 32:169–179. 2015. View Article : Google Scholar
|
|
17
|
Wang SC, Lin XL, Wang HY, Qin YJ, Chen L,
Li J, Jia JS, Shen HF, Yang S, Xie RY, et al: Hes1 triggers
epithelial-mesenchymal transition (EMT)-like cellular marker
alterations and promotes invasion and metastasis of nasopharyngeal
carcinoma by activating the PTEN/AKT pathway. Oncotarget.
6:36713–36730. 2015.
|
|
18
|
Johnson EJ: A biological role of lutein.
Food Rev Int. 20:1–16. 2004. View Article : Google Scholar
|
|
19
|
Nwachukwu ID, Udenigwe CC and Aluko RE:
Lutein and zeaxanthin: Production technology, bioavailability,
mechanisms of action, visual function, and health claim status.
Trends Food Sci Technol. 49:74–84. 2016. View Article : Google Scholar
|
|
20
|
Sindhu ER, Firdous AP, Ramnath V and
Kuttan R: Effect of carotenoid lutein on
N-nitrosodiethylamine-induced hepatocellular carcinoma and its
mechanism of action. Eur J Cancer Prev. 22:320–327. 2013.
View Article : Google Scholar
|
|
21
|
Lakshminarayana R, Sathish UV, Dharmesh SM
and Baskaran V: Antioxidant and cytotoxic effect of oxidized lutein
in human cervical carcinoma cells (HeLa). Food Chem Toxicol.
48:1811–1816. 2010. View Article : Google Scholar
|
|
22
|
Rafi MM, Kanakasabai S, Gokarn SV, Krueger
EG and Bright JJ: Dietary lutein modulates growth and survival
genes in prostate cancer cells. J Med Food. 18:173–181. 2015.
View Article : Google Scholar
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
24
|
Chen J, Imanaka N, Chen J and Griffin JD:
Hypoxia potentiates Notch signaling in breast cancer leading to
decreased E-cadherin expression and increased cell migration and
invasion. Br J Cancer. 102:351–360. 2010. View Article : Google Scholar
|
|
25
|
Borggrefe T, Lauth M, Zwijsen A,
Huylebroeck D, Oswald F and Giaimo BD: The Notch intracellular
domain integrates signals from Wnt, Hedgehog, TGFβ/BMP and hypoxia
pathways. Biochim Biophys Acta. 1863:303–313. 2016. View Article : Google Scholar
|
|
26
|
Wang Y, Ma J, Shen H, Wang C, Sun Y,
Howell SB and Lin X: Reactive oxygen species promote ovarian cancer
progression via the HIF-1α/LOX/E-cadherin pathway. Oncol Rep.
32:2150–2158. 2014. View Article : Google Scholar
|
|
27
|
Reynoso-Camacho R, González-Jasso E,
Ferriz-Martínez R, Villalón-Corona B, Loarca-Piña GF, Salgado LM
and Ramos-Gomez M: Dietary supplementation of lutein reduces colon
carcinogenesis in DMH-treated rats by modulating K-ras, PKB, and
β-catenin proteins. Nutr Cancer. 63:39–45. 2011.
|
|
28
|
Sang L, Roberts JM and Coller HA:
Hijacking HES1: How tumors co-opt the anti-differentiation
strategies of quiescent cells. Trends Mol Med. 16:17–26. 2010.
View Article : Google Scholar
|
|
29
|
Gao F, Huang W, Zhang Y, Tang S, Zheng L,
Ma F, Wang Y, Tang H and Li X: Hes1 promotes cell proliferation and
migration by activating Bmi-1 and PTEN/Akt/GSK3β pathway in human
colon cancer. Oncotarget. 6:38667–38680. 2015. View Article : Google Scholar
|
|
30
|
Yilmaz M and Christofori G: EMT, the
cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev.
28:15–33. 2009. View Article : Google Scholar
|
|
31
|
Wong NKY, Fuller M, Sung S, Wong F and
Karsan A: Heterogeneity of breast cancer stem cells as evidenced
with Notch-dependent and Notch-independent populations. Cancer Med.
1:105–113. 2012. View Article : Google Scholar
|
|
32
|
Movafagh S, Crook S and Vo K: Regulation
of hypoxia-inducible factor-1a by reactive oxygen species: New
developments in an old debate. J Cell Biochem. 116:696–703. 2015.
View Article : Google Scholar
|
|
33
|
Zhang C, Cao S, Toole BP and Xu Y: Cancer
may be a pathway to cell survival under persistent hypoxia and
elevated ROS: A model for solid-cancer initiation and early
development. Int J Cancer. 136:2001–2011. 2015. View Article : Google Scholar
|
|
34
|
Cao L, Chen X, Xiao X, Ma Q and Li W:
Resveratrol inhibits hyperglycemia-driven ROS-induced invasion and
migration of pancreatic cancer cells via suppression of the ERK and
p38 MAPK signaling pathways. Int J Oncol. 49:735–743. 2016.
View Article : Google Scholar
|
